Literature DB >> 9032468

Differential regulation of extracellular signal-regulated protein kinase 1 and Jun N-terminal kinase 1 by Ca2+ and protein kinase C in endothelin-stimulated Rat-1 cells.

K Cadwallader1, J Beltman, F McCormick, S Cook.   

Abstract

The extracellular signal-regulated protein kinase (ERK) and Jun N-terminal kinase (JNK) signalling cascades transduce signals from the cell cytoplasm to the nucleus, where they regulate gene expression. The activation of ERK1 by lysophosphatidic acid (LPA) and endothelin 1 (Et-1) was compared in Rat-1 cells. Both stimulated DNA synthesis to a similar degree but, in contrast with LPA, Et-1 did not stimulate sustained ERK1 activation, a signal that is thought to be important for the proliferation of fibroblasts. Et-1, but not LPA, was able to activate JNK1; pharmacological analysis revealed that the same EtA receptor mediates DNA synthesis, ERK1 and JNK1 activation. However, activation of JNK1 required higher concentrations of Et-1 than was required for stimulation of ERK1 or DNA synthesis. Signalling to ERK1 and JNK1 was partly inhibited by pertussis toxin, suggesting that both pathways are regulated in part by Gi or G0 proteins. Activation of JNK1 by Et-1 lagged behind ERK1 activation but was not dependent on it because PD98059, an inhibitor of mitogen-activated protein kinase (or ERK) kinase, was without effect on JNK1 activation. In contrast with recent studies, activation of protein kinase C (PKC) or Ca2+ fluxes inhibited activation of JNK1 but not ERK1; furthermore inhibition of PKC or sequestration of Ca2+ potentiated JNK1 activation by Et-1 but not by anisomycin, and again had little effect on ERK1 activation. These results demonstrate that the same G-protein-coupled receptor can activate both the ERK and JNK signal pathways but the two kinase cascades seem to be separate, parallel pathways that are differentially regulated by PKC and Ca2+. The results are discussed in terms of the role of ERK and JNK in proliferative signalling.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9032468      PMCID: PMC1218137          DOI: 10.1042/bj3210795

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  61 in total

1.  Lysophosphatidate-induced cell proliferation: identification and dissection of signaling pathways mediated by G proteins.

Authors:  E J van Corven; A Groenink; K Jalink; T Eichholtz; W H Moolenaar
Journal:  Cell       Date:  1989-10-06       Impact factor: 41.582

2.  Modulation of RNA expression by intracellular calcium. Existence of a threshold calcium concentration for induction of VL30 RNA by epidermal growth factor, endothelin, and protein kinase C.

Authors:  K D Rodland; L L Muldoon; P Lenormand; B E Magun
Journal:  J Biol Chem       Date:  1990-07-05       Impact factor: 5.157

3.  Autoradiographic visualization of the binding sites for [125I]endothelin in rat and human brain.

Authors:  C R Jones; C R Hiley; J T Pelton; M Mohr
Journal:  Neurosci Lett       Date:  1989-02-27       Impact factor: 3.046

4.  ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF.

Authors:  T G Boulton; S H Nye; D J Robbins; N Y Ip; E Radziejewska; S D Morgenbesser; R A DePinho; N Panayotatos; M H Cobb; G D Yancopoulos
Journal:  Cell       Date:  1991-05-17       Impact factor: 41.582

5.  Cloning and expression of a cDNA encoding an endothelin receptor.

Authors:  H Arai; S Hori; I Aramori; H Ohkubo; S Nakanishi
Journal:  Nature       Date:  1990 Dec 20-27       Impact factor: 49.962

6.  Endothelin stimulates phospholipase C, Na+/H+ exchange, c-fos expression, and mitogenesis in rat mesangial cells.

Authors:  M S Simonson; S Wann; P Mené; G R Dubyak; M Kester; Y Nakazato; J R Sedor; M J Dunn
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

7.  Requirement for integration of signals from two distinct phosphorylation pathways for activation of MAP kinase.

Authors:  N G Anderson; J L Maller; N K Tonks; T W Sturgill
Journal:  Nature       Date:  1990-02-15       Impact factor: 49.962

8.  The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C.

Authors:  D Toullec; P Pianetti; H Coste; P Bellevergue; T Grand-Perret; M Ajakane; V Baudet; P Boissin; E Boursier; F Loriolle
Journal:  J Biol Chem       Date:  1991-08-25       Impact factor: 5.157

9.  Cellular stresses differentially activate c-Jun N-terminal protein kinases and extracellular signal-regulated protein kinases in cultured ventricular myocytes.

Authors:  M A Bogoyevitch; A J Ketterman; P H Sugden
Journal:  J Biol Chem       Date:  1995-12-15       Impact factor: 5.157

10.  ERK phosphorylation potentiates Elk-1-mediated ternary complex formation and transactivation.

Authors:  H Gille; M Kortenjann; O Thomae; C Moomaw; C Slaughter; M H Cobb; P E Shaw
Journal:  EMBO J       Date:  1995-03-01       Impact factor: 11.598

View more
  9 in total

Review 1.  Pharmacodynamics and toxicodynamics of drug action: signaling in cell survival and cell death.

Authors:  A N Kong; S Mandlekar; R Yu; W Lei; A Fasanmande
Journal:  Pharm Res       Date:  1999-06       Impact factor: 4.200

2.  Src-family tyrosine kinases, phosphoinositide 3-kinase and Gab1 regulate extracellular signal-regulated kinase 1 activation induced by the type A endothelin-1 G-protein-coupled receptor.

Authors:  S Bisotto; E D Fixman
Journal:  Biochem J       Date:  2001-11-15       Impact factor: 3.857

3.  Regulation of extracellular-signal regulated kinase and c-Jun N-terminal kinase by G-protein-linked muscarinic acetylcholine receptors.

Authors:  P G Wylie; R A Challiss; J L Blank
Journal:  Biochem J       Date:  1999-03-15       Impact factor: 3.857

4.  G-protein-coupled receptor agonists activate endogenous phospholipase Cepsilon and phospholipase Cbeta3 in a temporally distinct manner.

Authors:  Grant G Kelley; Katherine A Kaproth-Joslin; Sarah E Reks; Alan V Smrcka; Richard J H Wojcikiewicz
Journal:  J Biol Chem       Date:  2005-11-28       Impact factor: 5.157

5.  Retinoic acid uses divergent mechanisms to activate or suppress mitogenesis in rat aortic smooth muscle cells.

Authors:  S Chen; D G Gardner
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

6.  The repertoire of fos and jun proteins expressed during the G1 phase of the cell cycle is determined by the duration of mitogen-activated protein kinase activation.

Authors:  S J Cook; N Aziz; M McMahon
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

7.  Integrin-mediated activation of focal adhesion kinase is required for signaling to Jun NH2-terminal kinase and progression through the G1 phase of the cell cycle.

Authors:  M Oktay; K K Wary; M Dans; R B Birge; F G Giancotti
Journal:  J Cell Biol       Date:  1999-06-28       Impact factor: 10.539

8.  Inability of serotonin to activate the c-Jun N-terminal kinase and p38 kinase pathways in rat aortic vascular smooth muscle cells.

Authors:  A K Banes; R D Loberg; F C Brosius; S W Watts
Journal:  BMC Pharmacol       Date:  2001-10-08

9.  Endothelin 1-induced retinal ganglion cell death is largely mediated by JUN activation.

Authors:  Olivia J Marola; Stephanie B Syc-Mazurek; Gareth R Howell; Richard T Libby
Journal:  Cell Death Dis       Date:  2020-09-26       Impact factor: 8.469

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.